BOD — Bod Science Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual balance sheet for Bod Science, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 6.39 | 8.05 | 3.67 | 2.03 | 0.434 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.49 | 0.73 | 0.426 | 0.4 | 0.213 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8.44 | 9.98 | 4.88 | 3.3 | 2.28 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.03 | 0.03 | 0.015 | 0.075 | 0.007 |
| Net Intangible Assets | |||||
| Total Assets | 8.91 | 10.4 | 5.31 | 3.5 | 2.31 |
| Accounts Payable | |||||
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.82 | 1.69 | 1.78 | 3.62 | 7.58 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 4.11 | 1.69 | 1.85 | 4.21 | 7.63 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 4.81 | 8.66 | 3.47 | -0.703 | -5.32 |
| Total Liabilities & Shareholders' Equity | 8.91 | 10.4 | 5.31 | 3.5 | 2.31 |
| Total Common Shares Outstanding |